Asia Pacific Point Of Care Diagnostics Market Forecasted to Surge, Reaching USD 15.61 Billion by 2030 with a CAGR of 8.1%
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The Asia Pacific Point Of Care Diagnostics Market is poised for a substantial uptick, as a new analysis indicates the market size is set to expand rapidly, with projections estimating a market size of USD 15.61 billion by 2030, with a consistent CAGR of 8.1% from 2023 to 2030. The swell in market size is attributed to a multitude of factors including a burgeoning geriatric population, swift advancements in healthcare technology, and an escalating demand for immediate diagnostic results that bolster patient care.
Growing adoption of Point Of Care (PoC) diagnostic solutions plays a pivotal role in the decentralization of healthcare, facilitating remote medical support, contributing to the efficiency of medical diagnosis, and potentially decreasing healthcare costs. The impetus behind this market acceleration also includes facility shortages of skilled staff, prompting automation in labs and further driving the adoption of PoC products, ensuring immediate and accurate results for a variety of testing applications.
Market Dynamics
Infectious diseases testing represents a significant share of the market, reflecting the shift to PoC diagnostics over traditional laboratory methods.
Cancer markers testing segments are projected to witness the fastest growth, amid rising cancer prevalence across the Asia Pacific region.
Clinics as end-users command a substantial portion of the market revenue, showcasing the key role they play in delivering healthcare services, especially within rural and underprivileged communities.
China retains a dominant position in the market, partly due to the country's vast population and the corresponding challenges related to chronic and infectious diseases.
Regional Insights
The findings illuminate China's profound impact on the regional market, with a significant revenue share driven by the nation's need to manage an expansive population alongside increased incidences of diverse health conditions.
With a focus on the Asia Pacific region and a detailed assessment of diverse segments including product type and end-use application, this latest market analysis provides invaluable insights for stakeholders in the healthcare industry, including healthcare providers, policymakers, and medical device manufacturers.
As the demand for versatile healthcare solutions and efficient patient care persists, the Asia Pacific Point Of Care Diagnostics Market is expected to thrive, charting significant progress in combating health challenges in the region through instant and reliable diagnostic care.
For comprehensive information on methodologies and data sources used in this market analysis, please visit our report in the research publications section on our website.
Key Attributes
Report Attribute | Details |
No. of Pages | 120 |
Forecast Period | 2022 - 2030 |
Estimated Market Value (USD) in 2022 | $8.17 Billion |
Forecasted Market Value (USD) by 2030 | $15.61 Billion |
Compound Annual Growth Rate | 8.1% |
Regions Covered | Asia Pacific |
Companies Mentioned
Wipro
ZOE Limited
Vocalis Health
DarwinAI
Biocogniv Inc.
Laipac Technology Inc.
Gauss Surgical, Inc.
Oxford Immune Algorithmics Ltd
F. Hoffmann-La Roche Ltd.
QIAGEN
Danaher
Beckman Coulter, Inc.
Radiometer Medical ApS
HemoCue AB
BD (Becton, Dickinson, and Company)
BIOMÉRIEUX
Abbott
Siemens Healthcare GmbH
Zoetis Services LLC
Abaxis
Instrumentation Laboratory Company
Nova Biomedical
Trividia Health, Inc.
Quidel Corporation
Trinity Biotech
SEKISUI Diagnostics
Orasure Technologies, Inc.
Nipro Europe Group Companies
Spectral Medical Inc.
Key Topics Covered
Methodology and Scope
Market Segmentation & Scope
Research Methodology
Information Procurement
Information or Data Analysis
Market Formulation & Validation
Model Details
List of Secondary Sources
List of Primary Sources
Objectives
Executive Summary
Market Outlook
Segment Outlook
Competitive Insights
Asia Pacific Point Of Care Diagnostics Market Variables, Trends & Scope
Market Lineage Outlook
Penetration & Growth Prospect Mapping
Market Dynamics
Point Of Care Diagnostics Market Analysis Tools
Asia Pacific Point Of Care Diagnostics: Product Estimates & Trend Analysis
Point Of Care Diagnostics Market: Key Takeaways
Point Of Care Diagnostics Market: Movement & Market Share Analysis
Glucose Testing
Hb1Ac Testing
Coagulation
Fertility/Pregnancy
Infectious Diseases
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug Abuse Testing
Autoimmune Disease
Urinalysis/Nephrology
Asia Pacific Point Of Care Diagnostics Market: End Use Estimates & Trend Analysis
Point Of Care Diagnostics Market: Key Takeaways
Point Of Care Diagnostics Market: Movement & Market Share Analysis
Clinics
Hospitals
Home
Assisted Living Healthcare Facilities
Laboratory
Asia Pacific Point Of Care Diagnostics Market: Regional Estimates & Trend Analysis
Regional Outlook
Point Of Care Diagnostics Market by Region: Key Marketplace Takeaway
Asia Pacific
Competitive Landscape
Recent Developments & Impact Analysis, By Key Market Participants
Market Participant Categorization
For more information about this report visit https://www.researchandmarkets.com/r/34hjg6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900